Skip to main content
Premium Trial:

Request an Annual Quote

Ronald Faris, Heidi Bullock, and Stephen David

Premium

MultiCell Technologies said last week that Ronald Faris, the company's senior vice president and chief science officer, has signed a new employment contract increasing his time commitment to MultiCell.

Faris retains his affiliation with Rhode Island Hospital, and remains an associate professor of pathology and pediatrics at Brown University, MultiCell said.


Heidi Bullock has left her position as director of marketing for Vitra Biosciences, CBA News learned last week. No further details were given regarding her departure or replacement.


Stephen David has joined Nonlinear Dynamics' strategic marketing team, the Newcastle upon Tyne, UK-based company said this week. He comes to Nonlinear from GE Healthcare, formerly Amersham Biosciences, where he worked as DiGE global applications specialist.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.